Medication non-adherence is one important reason behind sub-optimal outcome from treatment of bipolar affective disorder (BPAD). Though various reasons behind medication non-adherence have been identified, little is known about the medication adherence patterns across various predominant polarities (PP) in BPAD.
Methods
100 euthymic patients of BPAD were purposively recruited and the PP were determined. Subsequently, Morisky Medication adherence scale (MMAS); Global Assessment of Functioning (GAF); Oslo Social Support Scale and World Health Organization Quality of Life scale- Brief version (WHOQOL-Bref) were administered. Analysis of covariance (ANCOVA) was done to estimate the difference of scores of MMAS after adjusting for any potential confounders.
Results
Overall, 44 patients with manic PP (MPP), 17 with depressive PP (DPP) and 39 with indeterminate PP (IPP) were recruited. It was found that patients who presented with DPP showed significantly higher medication adherence as compared to MPP.
Conclusion
Knowledge of PP of a patient of BPAD can be useful in anticipating medication adherence and treatment outcome. The major limitations included non-probability sampling, cross-sectional design and limited generalizability of the results.
BerkLHallamKTColomF, et al.
Enhancing medication adherence in patients with bipolar disorder. Human Psychopharmacol2010;
25: 1–16.
2.
HaynesRBAcklooESahotaN, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev, https://pubmed.ncbi.nlm.nih.gov/18425859/ (2008, accessed 30 March 2021)
3.
LichtRWVestergaardPRasmussenNA, et al.
A lithium clinic for bipolar patients: 2-year outcome of the first 148 patients. Acta Psychiatr Scand2001;
104: 387–390.
4.
SajatovicMValensteinMBlowFC, et al.
Treatment adherence with antipsychotic medications in bipolar disorder.Bipolar Disord2006;
8: 232–241.
5.
ColomFVietaEMartinez-AranA, et al.
Clinical factors associated with treatment noncompliance in euthymic bipolar patients.J Clin Psychiatry2000;
61: 549–555.
6.
LingamRScottJ.Treatment non-adherence in affective disorders. Acta Psychiatr Scand2002;
105: 164–172.
7.
LeclercEMansurRBBrietzkeE.Determinants of adherence to treatment in bipolar disorder: a comprehensive review.J Affect Disord2013;
149: 247–252.
8.
LevinJBKrivenkoAHowlandM, et al.
Medication adherence in patients with bipolar disorder: a comprehensive review.CNS Drugs2016;
30; 819–835.
9.
MurruAPacchiarottiIAmannBL, et al.
Treatment adherence in bipolar I and schizoaffective disorder, bipolar type. J Affect Disord2013;
151: 1003–1008.
10.
SajatovicMBiswasKKilbourneAK, et al.
Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder. Psychiatr Serv2008;
59: 753–759.
11.
ColomFVietaESuppesT.Predominant polarity in bipolar disorders: refining or redefining diagnosis?Acta Psychiatr Scand2015;
132: 324–326.
12.
BelizarioGOGiganteADde Almeida RoccaCC, et al.
Cognitive impairments and predominant polarity in bipolar disorder: a cross-sectional study.Int J Bipolar Disord2017;
5: 15.
13.
PalA.A cross-sectional study of internalized stigma in euthymic patients of bipolar disorder across its predominant polarity. Indian J Soc Psychiatry2020;
36: 73.
14.
NivoliAMAColomFPacchiarottiI, et al.
Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: a principal component analysis of lifetime pharmacological and biophysic treatment options.Eur Neuropsychopharmacol2013;
23: 263–275.
15.
CochranSDGitlinMJ.Attitudinal correlates of lithium compliance in bipolar affective disorders.J Nerv Ment Dis1988;
176: 457–464.
16.
PalASharanPChaddaRK.Internalized stigma and its impact in Indian outpatients with bipolar disorder.Psychiatry Res2017;
258: 158–165.
17.
De las CuevasCPeñateW.Psychometric properties of the eight-item Morisky Medication Adherence Scale (MMAS-8) in a psychiatric outpatient setting.Int J Clin Heal Psychol2015;
15: 121–129. Available from:/pmc/articles/PMC6224788/?report = abstract
18.
AasIM.Global Assessment of Functioning (GAF): properties and frontier of current knowledge. Ann Gen Psychiatry2010;
9: 20.
19.
KocaleventRDBergLBeutelME, et al.
Social support in the general population: standardization of the Oslo Social Support Scale (OSSS-3). BMC Psychol2018;
6: 31.
GarcíaSMartínez-CengotitabengoaMLópez-ZurbanoS, et al.
Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients. J Clin Psychopharmacol2016;
36: 355–371.
22.
SoléBJiménezETorrentC, et al.
Cognitive impairment in bipolar disorder: treatment and prevention strategies.Int J Neuropsychopharmacol2017;
20: 670–680.
23.
BurdickKERussoMFrangouS, et al.
Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications.Psychol Med2014;
44: 3083.
24.
BaldessariniRJPerryRPikeJ.Factors associated with treatment nonadherence among US bipolar disorder patients.Hum Psychopharmacol2008;
23: 95–105.
25.
ColomFVietaEDabanC, et al.
Clinical and therapeutic implications of predominant polarity in bipolar disorder.J Affect Disord2006;
93: 13–17.
26.
Gonzalez-PintoAMosqueraFAlonsoM, et al.
Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment.Bipolar Disord2006;
8: 618–624.
27.
PalA.Predominant polarity in bipolar affective disorder: a scoping review of its relationship with clinical variables and its implications.Indian J Psychol Med2019;
41: 9–17.
28.
BaldessariniRJUndurragaJVázquezGH, et al.
Predominant recurrence polarity among 928 adult international bipolar I disorder patients.Acta Psychiatr Scand2012;
125: 293–302.
29.
ZeberJECopelandLAGoodCB, et al.
Therapeutic alliance perceptions and medication adherence in patients with bipolar disorder.J Affect Disord2008;
107: 53–62.
30.
PopovicDTorrentCGoikoleaJM, et al.
Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study.Acta Psychiatr Scand2014;
129: 366–374.
